ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Ramm Pharma Corp

Ramm Pharma Corp (RAMM)

0.015
0.00
(0.00%)
Closed January 19 3:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.015
Bid
0.015
Ask
0.025
Volume
-
0.00 Day's Range 0.00
0.005 52 Week Range 0.065
Previous Close
0.015
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
58,715
Financial Volume
-
VWAP
-

RAMM Latest News

RAMM Pharma Commences Epifractán™ Sales through Peruvian Pharmacies and Scales up Exports to Brazil

TORONTO, Oct. 08, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Announces Approval and Registration of Epifractán™ 2% by Peru’s Ministry of Health

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Announces Approval and Registration of Epifractán™ 5% by Peru’s Ministry of Health and Enters Distribution A...

TORONTO, July 09, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma announces its quarter financial results for Q2 2020

TORONTO, June 29, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

TORONTO, April 15, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announces its intention to commence a normal course...

RAMM Pharma Corp. Announces Postponement of Filing of Interim Financial Statements

TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX™ 10 (cannabidiol) Oral Solution

TORONTO, March 26, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Corp. Provides Details on Operational Activities to Support COVID-19 Medical Response Effort & Corporate Update

TORONTO, March 23, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Corp. to Acquire NettaLife, a Leading Developer of Cannabis-Based Products for Pets and Large Animals

TORONTO, Feb. 25, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

RAMM Pharma Corp. Welcomes Legalization of Medical Cannabis in Brazil

TORONTO, Dec. 05, 2019 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), a leader in plant-derived cannabinoid pharmaceutical...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.0150.020.015645740.015CS
40.005500.010.020.01492360.015CS
120.005500.010.020.005587150.01439827CS
26-0.005-250.020.020.005328160.01529417CS
52-0.03-66.66666666670.0450.0650.005449820.0238178CS
156-0.29-95.08196721310.3050.350.005739690.12286371CS
260-0.925-98.40425531910.941.190.005826190.35495058CS

RAMM - Frequently Asked Questions (FAQ)

What is the current Ramm Pharma share price?
The current share price of Ramm Pharma is $ 0.015
What is the 1 year trading range for Ramm Pharma share price?
Ramm Pharma has traded in the range of $ 0.005 to $ 0.065 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CURE.XBiocure Technology Inc
$ 0.035
(133.33%)
7k
MYCOMydecine Innovations Group Inc
$ 0.01
(100.00%)
4.5k
TGIF1933 Industries Inc
$ 0.01
(100.00%)
1.3M
CEGCerro Grande Mining Corporation
$ 0.01
(100.00%)
1.2k
PUMPStock Trend Capital Inc
$ 0.01
(100.00%)
215.4k
ENRTEnertopia Corp
$ 0.05
(-75.00%)
1,000
CVGRCity View Green Holdings Inc
$ 0.005
(-50.00%)
141k
ASTIAquarius Surgical Technologies Inc
$ 0.01
(-50.00%)
2k
MLKMMayo Lake Minerals Inc
$ 0.015
(-40.00%)
100.5k
SLZSlave Lake Zinc Corp
$ 0.015
(-40.00%)
10k
SOLSOL Global Investments Corp
$ 0.415
(-15.31%)
4.68M
BCBCBC Bud Corporation
$ 0.12
(20.00%)
4.32M
CSSCascada Silver Corp
$ 0.04
(0.00%)
2.82M
SNAStar Navigation Systems Group Ltd
$ 0.005
(0.00%)
2.81M
DMCDunbar Metals Corp
$ 0.16
(6.67%)
2.58M

Discussion

View Full Feed
splintered sunlight splintered sunlight 2 minutes ago
Ya think??????????????
BBUZ
Sheddoggie Sheddoggie 2 minutes ago
NOBODY is going to lend Henry $12.5 billion.

Henries track record speaks for itself. You can go all the way back 30 years and see that Henry has been trying the same cons since then. That said...I'll buy a few mill as soon as this hits .0001 again. Still plenty of stupid people believ
PHIL
LakeshoreLeo1953 LakeshoreLeo1953 2 minutes ago
I assume from your comment that your area(s) of expertise/experience is in family care?
Does it expand beyond that?
Scientific or Corporate biotech?

Unsure what imprimatur you wish for your input.
AVXL
CaptBeer CaptBeer 3 minutes ago
How's your Italian?
https://www.pharmastar.it/pharmastartv//business/amarin-introduce-in-italia-un-nuovo-farmaco-contro-il-rischio-cardiovascolare-residuo-13781
AMRN
KVM KVM 3 minutes ago
Agree. On a side note is GRRR on your ai radar. Baisicly do same thing as Veri and involved in more. Have a law enforcement platform and involved in smart cities in international markets and just now getting into US market. See my comments on GRRR board
GRRR
jbog jbog 3 minutes ago
Mufasco,

I agree with you that they are in the copy and modification mode, but keep in mind they can do it at a fraction of the cost. U.S and Euro research has become unsustainable considering the monies that are spent. This is why research Bio's have been a group to avoid.
FACT-MASTER FACT-MASTER 3 minutes ago
Let's ROCK!!

https://www.google.com/search?client=opera&q=village+people+ymca&sourceid=opera&ie=UTF-8&oe=UTF-#fpstate=ive&vld=cid:7575fd1b,vid:_DRNljTgiyg,st:0
DJT
mick mick 3 minutes ago
GOOD MORNING
SkyLimit2022 SkyLimit2022 4 minutes ago
suit,

Thanks for asking 😶

Your posts, the ASM recording, and the trial data are there for anyone to read/listen to judge for themselves.

Thanks again for reminding us about the ASM and about past DCVax Direct clinical study at MD Anderson that i
ASM
wadegarret wadegarret 4 minutes ago
Scrap that Wadegarret buy on Monday

eom
Smartypants2 Smartypants2 4 minutes ago
LIAR! No, I take that back...F-ing LIAR! Your so-called research is half-assed at best. You refuse to accept anything that contradicts your preconceived opinions and then accuse others of acting in bad faith -- and much worse!
XERI
frrol frrol 5 minutes ago
You'll have memory problems of this, too. And will make further such mistakes. You have to work on it.
AVXL
Gmenfan Gmenfan 5 minutes ago
And the liberal's hate for America continues.............
GBR GBR 7 minutes ago
Regarding CS and his enthusiasm.

Yeah he did a lot better at communicating to the investing public, which gave more attention to the stock. But in hindsight, some of his comments were obviously misleading.

The big ones were his tipping point comments. Even if true at
VERI
Trinityz1 Trinityz1 7 minutes ago
THAT is funny!
georgejjl georgejjl 7 minutes ago
Plexrec,

Did you actually listen to the recent JPM Healthcare Conference where Dr. Missling PhD said that there would be a more detailed presentation concerning the OLE study later in the spring of 2025???

The following is what he meant.

https://investors
JPM
samk samk 9 minutes ago
"blarcamesine has proven through nine years of drug trial results, that it is the best drug to treat Alzheimer disease and should be the new SOC drug. Peer review results is the stamp of approval by the experts. Period!"
Bravo, bb8675309! - stamp of approval. The FUD has no shame.
AVXL
Dallas-Cowboys Dallas-Cowboys 9 minutes ago
Permits are no longer the issue, they will come in time. Contracts will become the issue for FID, once permits in hand contracts need to follow or before. I can't see this management team FID until contracts in hand and the top button of their shirts buttoned.
TGLO
Trinityz1 Trinityz1 9 minutes ago
1 more day
Smartypants2 Smartypants2 10 minutes ago
I KNOW THE TRUTH (having spoken to Braverman and Duffy about iT). You have refused to accept it or even try to verify it for yourself! Contact Braverman via LinkedIn and he will confirm everything!
XERI
Implanting Implanting 11 minutes ago
IMO this is getting way out of hand and Trump is right in there promoting the scam. This is part of the EVERYTHING BUBBLE that we're seeing in the market now. Crypto FOMO. This is not far from the dot-com bust of the late nineties. Everyone, including Trump, trying to scam people out of their money.
FFMGF
theorysuit theorysuit 11 minutes ago
Where did i misspeak?

-zero ORR (best response was SD) in Phase 1 10 years ago. Did they update that information with any ORR responses? Absolutely TRUE You do know that SD isn't included in ORR right? Or do i need to educate you there?
-LP said reviving the Direct program
NWBO
LetGoodTimesRoll LetGoodTimesRoll 11 minutes ago
FACTS!

$RNVA ==>$FOXO "problems" are a thing of the past.

GET READY TO RIDE SHAREHOLDERS!!!!
FOXO RNVA

Your Recent History

Delayed Upgrade Clock